The UK Focal Point on Drugs' (part of Public Health England) annual report on the United Kingdom drug situation, providing updates for 2017. The report contains details of hepatitis C prevalence and incidence rates among injecting drug users, levels of testing, diagnosis and treatment for hepatitis C and prevention efforts by UK governments.
Resources
Commissioner
NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care. Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.
Showing 1 to 10 of 398 resources
-
United Kingdom drug situation: Focal Point annual report 2017
UK Reports & Research PDF -
Taking the initiative: how England is eliminating hepatitis C
This report explores the unprecedented hepatitis C elimination programme developed since 2019 between NHS England, pharmaceutical industry providers, voluntary sector bodies and other partners, and profiles ‘elimination initiatives’ that have been developed in different parts of the country and wider health and care system as a result.England 21 Feb 2023 Reports & Research PDF -
A Census of Medical Workforce & Infrastructure for Liver Disease Strategy: Summary of Findings
As part of the National Liver Disease Strategy (NLDS), this document summarises the findings of a Census of the Medical Workforce (Consultant Gastroenterologists and Hepatologists). The census was undertaken with the aim of assessing the current capacity and infrastructure for delivery of Liver services in England, to identify which secondary care pathways already exist for referral and management, to understand how the current secondary care services relate to burden of disease, and to assess future training needs and capacity for liver services.England 2011 Reports & Research, Strategy & Planning PDF -
A Matter of Chance: An Audit of Hepatitis C Healthcare in England
In February 2006, more than 18 months after the launch of the Department of Health's 2004 Action Plan for Hepatitis C setting out required actions for Primary Care Trusts (PCTs) and NHS Hospital Trusts, the All-Party Parliamentary Hepatology Group undertook a survey of PCTs and NHS Hospital Trusts in order to audit what actions they had taken to fulfil the Action Plan’s stated requirements. 'A Matter of Chance' reports on the findings of this research.UK May 2006 Reports & Research PDF -
A peer-based needle exchange service in London
Funded by Hackney Council as part of the ADDER (addiction, diversion, disruption, enforcement and recovery) Accelerator project, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) have a released a report exploring the feasibility, acceptability, and practical considerations of developing a peer-based needle exchange service. It draws on focus groups with people who use needle exchange services and peer support workers, interviews with experts from services and commissioning bodies, and international evidence.Greater London 18 Jan 2022 Reports & Research PDF -
A Time to Act: Improving Liver Health and Outcomes in Liver Disease
This document reviews the current landscape of UK liver disease and advises the Department of Health on ways to improve liver services and the outcomes of liver disease in the UK. It stresses the fact that radical change in the profile of the disease is achievable, and includes recommendations on cost-effective and high quality management of liver disease and liver services, the establishment of training frameworks and the setting of clinical standards, quality metrics and guidelines for the monitoring and assessment of local services.UK 2009 Reports & Research, Strategy & Planning PDF -
Access and Uptake of Direct Acting Antiviral Medicines in the UK and selected European countries
This report, produced by IMS Health and commissioned by the Association of the British Pharmaceutical Industry (ABPI), provides information related to the uptake of Direct Acting Antiviral treatments (DAAs) over the last five years, to June 2016. The intention of the report is to benchmark the UK – in relation to patient access to these medicines – compared with other European countries. It finds that there have been significant variances in the ability of patients to access these medicines.UK Feb 2017 Reports & Research PDF -
Action Plan for the Prevention, Management and Control of Hepatitis C in Northern Ireland
The actions set out in this report form the core of a plan to address hepatitis C in Northern Ireland for the period 2006-2008. Its aim is to achieve a reduction in the transmission of hepatitis C in Northern Ireland and to ensure that people with hepatitis C infection are identified and receive high quality, evidence-based, patient-focused treatment and care.Northern Ireland Jan 2007 Reports & Research, Strategy & Planning PDF -
Addaction Hepatitis C Strategy
Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.UK Strategy & Planning PDF -
Addressing hepatitis C in prisons and other places of detention
A report from The Hepatitis C Trust providing recommendations for hepatitis C healthcare service in prisons and other detention settings in the UK.
UK May 2013 Reports & Research PDF